Position in QNCX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$11,231
-$23,500,409 QoQ
Shares Held
556
-98.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 46 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 32.55395683453237.ToString("F0")%
Shared 0.ToString("F0")%
None 67.44604316546763.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Derivatives in QNCX
reported options exposure · as of Sep 30, 2021CallValue
$0
CallShares
0
PutValue
$920,266,400
PutShares
50,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. QNCX ranks #460 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in QNCX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,231 | 556 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $23,511,640 | 35,092 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $479,872 | 1,472 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $939,180 | 2,846 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $187,796 | 706 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $416,636 | 1,114 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $74,496 | 480 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $72,000 | 480 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $107,060 | 505 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $106,050 | 505 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,493,632 | 6,668 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $274,512 | 912 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $101,400 | 325 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,843,710 | 45,869 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $8,858,864 | 33,304 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $11,154,612 | 25,123 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $31,675,468 | 25,586 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $39,505,648 | 15,652 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $920,266,400 | 50,200 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $311,460,680 | 16,990 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $107,547,600 | 10,146 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $258,090,096 | 35,816 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $58,638,024 | 10,554 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $203,710,000 | 20,371 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $212,563,300 | 22,955 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $237,847,028 | 26,074 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||